bupropion has been researched along with sertraline in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (17.57) | 18.2507 |
| 2000's | 28 (37.84) | 29.6817 |
| 2010's | 25 (33.78) | 24.3611 |
| 2020's | 8 (10.81) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Burke, M; Preskorn, SH | 1 |
| Loskutova, LV; Luk'ianenko, FIa | 1 |
| Preskorn, SH | 1 |
| Grimes, JB; Labbate, LA | 1 |
| DePalma, RL; Katholi, CR; Modell, JD; Modell, JG | 1 |
| Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
| Ascher, JA; Hughes, AR; Johnston, JA; Kavoussi, RJ; Segraves, RT | 1 |
| Grimes, JB; Hines, A; Labbate, LA; Pollack, MH | 1 |
| Connor, KM; Davidson, JR | 1 |
| Asnis, G; Efremova, I | 1 |
| Anand, VS; Dewan, MJ | 1 |
| Ascher, JA; Batey, SR; Croft, H; Donahue, RM; Houser, T; Settle, E | 1 |
| Ascher, JA; Batey, SR; Coleman, CC; Cunningham, LA; Donahue, RM; Foster, VJ; Houser, TL | 1 |
| Ascher, JA; Batey, SR; Donahue, R; Hughes, AR; Johnston, JA; Kavoussi, R; Segraves, RT | 1 |
| Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL | 1 |
| Ferguson, JM | 1 |
| Ascher, JA; Batey, SR; Bolden-Watson, C; Carmody, TJ; Donahue, RM; Houser, TL; Metz, A; Rush, AJ; Trivedi, MH | 1 |
| Bolden-Watson, C; Carmody, TJ; Donahue, RM; Houser, TL; Metz, A; Rush, AJ; Trivedi, MH | 1 |
| Bagby, RM; Kennedy, SH; Vanderkooy, JD | 1 |
| Barros, DM; Izquierdo, I; Izquierdo, LA; Medina, JH | 1 |
| Johnson, B; Kennedy, JS; Mignot, E; Nishino, S; Ripley, B; Salomon, RM; Schmidt, D; Zeitzer, JM | 1 |
| DeVane, CL; Donovan, JL; Gibson, BB; Markowitz, JS; Wang, JS; Zhu, HJ | 2 |
| Johnson, BW; Salomon, RM; Schmidt, DE | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Martinez, MI; McElroy, SL; Nolen, WA; Post, RM; Suppes, T | 1 |
| Biggs, MM; Fava, M; Luther, JF; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Akarsu, ES; Ayhan, IH; Cankurtaran, ES; Cekic, T; Ozalp, E; Palaoglu, O; Soygur, H; Turhan, L | 1 |
| Csoka, AB; Shipko, S | 1 |
| Barea, BM; Carvalho, AF; Chaves, ML; Cruz, EP; Izquierdo, I; Köhler, CA; Reichman, BP; Stürmer, PL | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
| Astuccio, AV; Obach, RS; Walsky, RL | 1 |
| Shelton, RC | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
| Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Altshuler, LL; Black, DO; Frye, MA; Grunze, H; Helleman, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, WA; Post, RM; Suppes, T | 1 |
| Altshuler, LL; Frye, MA; Grunze, H; Hellemann, G; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Sugar, CA; Suppes, T | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ | 1 |
| Anderson, RJ; Freedland, KE; Gott, BM; Lustman, PJ; Sayuk, GS | 1 |
| Lo, V; Maggio, L | 1 |
| Fujioka, Y; Hachad, H; Isoherranen, N; Levy, RH; Yeung, CK | 1 |
| Bartell, SE; Furlong, ET; Logue, A; Painter, MM; Schoenfuss, HL; Schultz, MM; Werner, SL | 1 |
| Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 2 |
| Calandra, C; Luca, M; Russo, RG | 1 |
| Hassan, HE; Molnari, JC; Myers, AL | 1 |
| Fava, M; Perlis, RH; Perroud, N; Uher, R | 1 |
| Chung, CP; Morrow, JD; Salomon, RM; Schmidt, D; Stein, CM | 1 |
| Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR | 1 |
| Farinde, A | 1 |
| Clarke, W; Jannetto, PJ; Johnson-Davis, KL; Langman, LJ; Marzinke, MA; Moskowitz, J; Petrides, AK | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Chen, S; Conwell, Y; He, J; Lu, N; Wu, J | 1 |
| Brooks, MM; Luther, JF; Potter, MA; Roberts, MS; Singh, A; Voorhees, RE; Wisniewski, SR | 1 |
| Aalto-Setälä, M; Brignone, M; Campbell, R; Cure, S; Danchenko, N; Diamand, F; Hallinen, T; Kolasa, K; Koponen, H; Soini, E | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Adams, P; Almeida, J; Ang, YS; Bruder, G; Carmody, T; Chase, HW; Chin Fatt, CR; Cooper, CM; Deckersbach, T; Deldin, P; Fava, M; Kaiser, R; McGrath, P; McInnis, MG; Oquendo, MA; Parsey, R; Phillips, ML; Pizzagalli, DA; Trivedi, MH; Webb, CA; Weissman, M | 1 |
| Jain, SB; Jha, MK; Rush, AJ; South, C; Trivedi, MH | 1 |
| Alschuler, DM; Ang, YS; Bruder, GE; Carmody, T; Cooper, CM; Cusin, C; Deldin, P; Fava, M; Keilp, JG; McGrath, PJ; McInnis, MG; Oquendo, MA; Parsey, R; Pechtel, P; Pizzagalli, DA; Rutherford, A; Trivedi, MH; Webb, CA; Weissman, M | 1 |
| Hanna, K; Hatch, L; Herr, J; Sephien, A | 1 |
| Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
| Baugh, TB; Carr, CN; Reed, E; Sochacki, M; Straley, CM | 1 |
| Chin Fatt, C; Cooper, C; Fava, M; Jha, MK; Kurian, B; McGrath, PJ; Mellema, C; Montillo, AA; Nguyen, KP; Phillips, ML; Treacher, A; Trivedi, MH; Weissman, M | 1 |
| Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A | 1 |
7 review(s) available for bupropion and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Somatic therapy for major depressive disorder: selection of an antidepressant.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Depressive Disorder; Humans; Nortriptyline; Sertraline; Tranylcypromine; Trazodone | 1992 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Bupropion sustained release: a therapeutic overview.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Humans; Placebos; Serotonin Agents; Sertraline; Treatment Outcome | 1998 |
The effects of antidepressants on sexual functioning in depressed patients: a review.
Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles | 2001 |
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
Are all antidepressants the same? The consumer has a point.
Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2023 |
23 trial(s) available for bupropion and sertraline
| Article | Year |
|---|---|
Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Bupropion; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Sertraline; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 1997 |
A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
Topics: Adult; Aged; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 1999 |
Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment.
Topics: Adult; Aged; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome | 1999 |
Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Sexual Behavior | 2000 |
Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline.
Topics: Adult; Aged; Anxiety; Bupropion; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Status Schedule; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2001 |
Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Carrier Proteins; Case-Control Studies; Circadian Rhythm; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Humans; Intracellular Signaling Peptides and Proteins; Male; Neuropeptides; Orexins; Radioimmunoassay; Selective Serotonin Reuptake Inhibitors; Sertraline | 2003 |
Central neurochemical ultradian variability in depression.
Topics: Adult; Antidepressive Agents; Bupropion; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Prognosis; Sertraline; Tryptophan | 2006 |
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2006 |
Acute treatment with the antidepressants bupropion and sertraline do not influence memory retrieval in man.
Topics: Adolescent; Adult; Antidepressive Agents; Bupropion; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Female; Humans; Male; Mental Recall; Neuropsychological Tests; Personality Inventory; Sertraline; Time Factors | 2006 |
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride | 2008 |
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Topics: Acute Disease; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort study.
Topics: Adult; Antidepressive Agents; Binge-Eating Disorder; Body Mass Index; Bupropion; Depressive Disorder; Female; Humans; Male; Overweight; Psychiatric Status Rating Scales; Retrospective Studies; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome; Weight Loss | 2012 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult | 2013 |
Depression care management for adults older than 60 years in primary care clinics in urban China: a cluster-randomised trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Bupropion; China; Depressive Disorder; Health Policy; Humans; Middle Aged; Patient Care Management; Primary Health Care; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2015 |
Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression.
Topics: Adult; Bupropion; Citalopram; Cost-Benefit Analysis; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2017 |
Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse.
Topics: Adult; Bupropion; Depressive Disorder, Major; Humans; Prospective Studies; Reward; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
Topics: Adult; Antidepressive Agents; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder, Major; Double-Blind Method; Humans; Sertraline; Treatment Outcome | 2022 |
Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.
Topics: Antidepressive Agents; Biomarkers; Brain; Bupropion; Calcium Phosphates; Depressive Disorder, Major; Humans; Reward; Sertraline; Treatment Outcome | 2022 |
44 other study(ies) available for bupropion and sertraline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Specifics of participation of dopaminergic and serotoninergic systems of the brain in latent inhibition based on pharmacological models].
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Avoidance Learning; Brain; Bupropion; Dopamine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Spontaneous orgasm with the combined use of bupropion and sertraline.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Orgasm; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Female; Fluoxetine; Humans; Male; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires | 1997 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 1997 |
Antidepressants in depressed patients with irritable bowel syndrome.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Bupropion; Colonic Diseases, Functional; Comorbidity; Depressive Disorder; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles | 2000 |
Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
Topics: Adult; Anxiety Disorders; Bupropion; Comorbidity; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Randomized Controlled Trials as Topic; Retrospective Studies; Sertraline; Treatment Outcome | 2001 |
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Bupropion; Male; Memory; Rats; Sertraline; Time Factors | 2002 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice.
Topics: Algorithms; Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Brain; Bupropion; Cytochrome P-450 CYP2D6; Drug Interactions; Male; Mice; Population; Risperidone; Serotonin Antagonists; Sertraline | 2006 |
Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report.
Topics: Adult; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Dyskinesias; Humans; Male; Mental Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6.
Topics: Algorithms; Alkynes; Antidepressive Agents, Second-Generation; Antifungal Agents; Area Under Curve; Benzoxazines; Bupropion; Clopidogrel; Clotrimazole; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Itraconazole; Kinetics; Microsomes, Liver; Molecular Structure; Oxazines; Platelet Aggregation Inhibitors; Raloxifene Hydrochloride; Reverse Transcriptase Inhibitors; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Sertraline; Ticlopidine; Xenobiotics | 2006 |
Augmentation strategies to increase antidepressant efficacy.
Topics: Algorithms; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Drug Synergism; Humans; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline | 2007 |
Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein.
Topics: Adenosine Triphosphatases; Algorithms; Antidepressive Agents; Antidepressive Agents, Second-Generation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Bupropion; Data Interpretation, Statistical; Humans; In Vitro Techniques; Protein Binding; Sertraline | 2008 |
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Statistics as Topic; Venlafaxine Hydrochloride; Young Adult | 2009 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Antidepressant pharmacotherapy in adults with type 2 diabetes: rates and predictors of initial response.
Topics: Adult; Aged; Antidepressive Agents; Biomarkers, Pharmacological; Bupropion; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Sertraline; Treatment Outcome | 2010 |
Clinical inquiries. What's best when a patient doesn't respond to the maximum dose of an antidepressant?
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Cognitive Behavioral Therapy; Depression; Humans; Imipramine; Lithium; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure | 2010 |
Are circulating metabolites important in drug-drug interactions?: Quantitative analysis of risk prediction and inhibitory potency.
Topics: Algorithms; Amiodarone; Area Under Curve; Biomarkers, Pharmacological; Biotransformation; Bupropion; Cytochrome P-450 Enzyme Inhibitors; Databases, Factual; Drug Interactions; Enzyme Inhibitors; Guidelines as Topic; Humans; Models, Biological; Sertraline; Toxicity Tests; United States; United States Food and Drug Administration | 2011 |
Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Cyclohexanols; Cyprinidae; Endocrine Disruptors; Female; Fluoxetine; Male; Reproduction; Sertraline; Testis; Venlafaxine Hydrochloride; Vitellogenins; Water Pollutants, Chemical | 2011 |
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Effects of sertraline on the pharmacokinetics of bupropion and its major metabolite, hydroxybupropion, in mice.
Topics: Animals; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Brain; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Drug Interactions; Enzyme Inhibitors; Male; Mice; Oxidoreductases, N-Demethylating; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution | 2012 |
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride | 2012 |
Increased oxidative stress in patients with depression and its relationship to treatment.
Topics: Adult; Antidepressive Agents; Biomarkers; Bupropion; Case-Control Studies; Depressive Disorder, Major; F2-Isoprostanes; Female; Humans; Male; Oxidative Stress; Sertraline; Severity of Illness Index; Young Adult | 2013 |
Antidepressants.
Topics: Antidepressive Agents; Benzofurans; Bupropion; Drugs, Generic; Humans; Indoles; Nortriptyline; Piperazines; Sertraline; Vilazodone Hydrochloride | 2013 |
The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum.
Topics: Antidepressive Agents; Bupropion; Chromatography, Liquid; Citalopram; Drug Stability; Humans; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Solid Phase Extraction; Tandem Mass Spectrometry | 2014 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Topics: Acetamides; Antidepressive Agents; Bupropion; Cost-Benefit Analysis; Decision Trees; Depressive Disorder, Major; Finland; Humans; Markov Chains; Models, Theoretical; Piperazines; Recurrence; Sertraline; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2017 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
27-year-old woman • postpartum seizures • PTSD • history of depression • Dx?
Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Depression, Postpartum; Female; Humans; Seizures; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome | 2021 |
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Comparison of the effect of citalopram, bupropion, sertraline, and tricyclic antidepressants on QTc: A cross-sectional study.
Topics: Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |